Erratum: Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes (PLoS ONE (2014) 9:9 (e106903) DOI: 10.1371/journal.pone.0106903);Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Brandau, Sven ^a   Jakob, Mark ^b   Bruderek, Kirsten ^a   Bootz, Friedrich ^b   Giebel, Bernd ^a   Radtke, Stefan ^a   Mauel, Katharina ^a   Jäger, Marcus ^a   Flohé, Stefanie B ^a   Lang, Stephan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; ENDOGLIN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; JANUS KINASE 2; L SELECTIN; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; NUCLEAR FACTOR KAPPA B1; NUCLEAR FACTOR KAPPA B2; PROTEIN NFATC1; PROTEIN NFATC2; PROTEIN NFRKB; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG; TLR4 PROTEIN, HUMAN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BONE MARROW; CELL FUNCTION; CELL ISOLATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; MESENCHYMAL STEM CELL; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RESPIRATORY BURST; SALIVARY GLAND; SIGNAL TRANSDUCTION; SUPERNATANT; BACTERIUM; IMMUNOLOGY; INNATE IMMUNITY; MESENCHYMAL STROMA CELL; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

BACTERIA; BONE MARROW; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MESENCHYMAL STROMAL CELLS; NEUTROPHILS; SALIVARY GLANDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84907226883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114201     Document Type: Erratum

References (46)

1. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4(5):267-274
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al (1999)Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147
3. Horwitz EM, Le BK, Dominici M, Mueller I, Slaper-Cortenbach I, et al (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7(5):393-395
4. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F,et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317
5. Le Blanc K, Mougiakakos D (2012) Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 12(5):383-396
6. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, et al Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371(9624):1579-1586
7. Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, et al (2010)Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59(12):1662-1669
8. Nuschke A (2013) Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis 10(1).
9. Jackson WM, Nesti LJ, Tuan RS (2012) Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther 3(3):20
10. Jakob M, Hemeda H, Bruderek K, Gerstner A O.H, Bootz F, et al (2013) Comparative functional cell biological analysis of mesenchymal stem cells of the head and neck region: potential impact on wound healing, trauma, and infection. Head Neck35(11):1621-1629
11. Jakob M, Bruderek K, Bootz F, Lang S, Brandau S (2013) Trying to unravel an unresolved issue in regenerative medicine: gene expression profiling of MSCs. Laryngorhinootologie92(7):462-469
12. Wang L, Zhao Y, Shi S (2012) Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration. J Dent Res 91(11):1003-1010
13. Zhang W, Ge W, Li C, You S, Liao L, et al (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13(3):263-271
14. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838-3843
15. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, et al (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111(3):1327-1333
16. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367-372
17. Brandau S, Jakob M, Hemeda H, Bruderek K, Janeschik S,et al (2010) Tissueresident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J Leukoc Biol 88:1005-1015
18. Hsu SC, Wang LT, Yao CL, Lai HY, Chan KY,et al (2013) Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells. Immunobiology 218(1):90-95
19. Cassatella MA, Mosna F, Micheletti A, Lisi V, Tamassia N, (2011) Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells 29(6):1001-1011
20. Beyrau M, Bodkin JV, Nourshargh S (2012) Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol 2(11):120134
21. Rotter N, Oder J, Schlenke P, Lindner U, Bohrnsen F,et al (2008): Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev 17(3):509-518
22. Jakob M, Hemeda H, Janeschik S, Bootz F, Rotter N, et al (2010) Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Stem Cells Dev 19(5):635-644
23. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U,et al (2005): Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33(11):1402-1416
24. Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, et al (2003) Mesenchymal stem cells in human secondtrimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88(8):845-852
25. Miao Z, Jin J, Chen L, Zhu J, Huang W, et al (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30(9):681-687
26. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, et al (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23(8):1105-1112
27. Rinker TE, Hammoudi TM, Kemp ML, Lu H, Temenoff JS (2014) Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment. Integr Biol (Camb) 6(3):324-37
28. Bieback K (2013) Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfus Med Hemother40(5):326-335
29. Griffiths S, Baraniak PR, Copland IB, Nerem RM, McDevitt TC (2013) Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. Cytotherapy 15(12):1469-1483
30. Bohrnsen F, Rotter N, Lindner U, Meier M, Wollenberg B, Rohwedel J, Kramer J: Human mesenchymal stromal cells from adipose tissue of the neck. Eur Arch Otorhinolaryngol 2012; 269 (12):2561-2570
31. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60(6):788-798
32. Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, et al (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11(2):150-156
33. Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 3(4):e1886
34. Seppanen E, Roy E, Ellis R, Bou-Gharios G, Fisk NM, et al (2013) Distant mesenchymal progenitors contribute to skin wound healing and produce collagen: evidence from a murine fetal microchimerism model. PLoS ONE 8(5):e62662
35. Swart JF, de . RookS, Hofhuis FM, Rozemuller H, van den BT, et al (2014) Mesenchymal stem cell therapy in proteoglycan induced arthritis. Ann Rheum Disdoi:10.1136/annrheumdis-2013-204147
36. Wang D, Zhang H, Liang J, Li X, Feng X, et al (2013) Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant 22(12):2267-2277
37. McDonald B, Kubes P (2011) Cellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation. J Mol Med (Berl) 89(11):1079-1088
38. Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16(3):133-144
39. Dumitru CA, Gholaman H, Trellakis S, Bruderek K, Dominas N, et al (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 129(4):859-869
40. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A,et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587-596
41. Mendes SC, Robin C, Dzierzak E (2005) Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny. Development 132(5):1127-1136
42. Kusadasi N, Groeneveld AB (2013) A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis. Shock 40(5):352-357
43. Suttmann H, Riemensberger J, Bentien G, Schmaltz D, Stockle M, et al (2006) Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res 66(16):8250-8257
44. Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, et al (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 129(9):2183-2193
45. Oeckinghaus A, Hayden MS, Gosh S (2011) Crosstalk in NFkB signaling pathways. Nat Immunol. 12(8):695-708
46. Sun SC (2012) The noncanonical NFkB pathway. Immunol Rev. 246(1):125-140.